✦ LIBER ✦

Model for growth hormone receptor activation based on subunit rotation within a receptor dimer

✍ Scribed by Eidne, Karin A; Parker, Michael W; Brown, Richard J; Adams, Julian J; Pelekanos, Rebecca A; Wan, Yu; McKinstry, William J; Palethorpe, Kathryn; Seeber, Ruth M; Monks, Thea A

Book ID: 109967013
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 422 KB
Volume: 12
Category: Article
ISSN: 1545-9993
DOI: 10.1038/nsmb977

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Common Model for Cytokine Receptor Act

A Common Model for Cytokine Receptor Activation: Combined Scissor-Like Rotation and Self-Rotation of Receptor Dimer Induced by Class I Cytokine

✍ Pang, Xiaodong; Zhou, Huan-Xiang 📂 Article 📅 2012 🏛 Biophysical Society 🌐 English ⚖ 103 KB

Novel Assays Based on Human Growth Hormo

Novel Assays Based on Human Growth Hormone Receptor as Alternatives to the Rat Weight Gain Bioassay for Recombinant Human Growth Hormone

✍ E.C. Roswall; V.R Mukku; A.B. Chen; E.H. Hoff; H. Chu; P.A. McKay; K.C. Olson; J 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Structure−Function Studies on the New Gr

Structure−Function Studies on the New Growth Hormone-Releasing Peptide, Ghrelin: Minimal Sequence of Ghrelin Necessary for Activation of Growth Hormone Secretagogue Receptor 1a ⊥

✍ Bednarek, Maria A.; Feighner, Scott D.; Pong, Sheng-Shung; McKee, Karen Kulju; H 📂 Article 📅 2000 🏛 American Chemical Society 🌐 English ⚖ 93 KB

Analysis of structure-activity relations

Analysis of structure-activity relationships based on the principle of structural conformity within the framework of a lattice model of receptors

✍ V. E. Kuz'min; S. V. Krutius 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 356 KB

P2Y 1 Antagonists: Combining Receptor-Ba

P2Y 1 Antagonists: Combining Receptor-Based Modeling and QSAR for a Quantitative Prediction of the Biological Activity Based on Consensus Scoring

✍ Costanzi, Stefano; Tikhonova, Irina G.; Ohno, Michihiro; Roh, Eun Joo; Joshi, Bh 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 518 KB

Defining the biologically active dose fo

Defining the biologically active dose for PTK787/ZK222584 (ptk/zk), a vascular endothelial growth factor (VEGF) receptor inhibitor, based on the assessment of two biomarkers [dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), plasma VEGF] in two phase I studies

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 141 KB